High-dose monoclonal antibodies via the subcutaneous route: Challenges and technical solutions, an industry perspective

Chakravarthy Narasimhan; Henryk MacH; Mohammed Shameem

doi:10.4155/tde.12.68

High-dose monoclonal antibodies via the subcutaneous route: Challenges and technical solutions, an industry perspective

Chakravarthy Narasimhan, Henryk MacH, Mohammed Shameem^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Abstract

This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.

Original language	English
Pages (from-to)	889-900
Number of pages	12
Journal	Therapeutic Delivery
Volume	3
Issue number	7
DOIs	https://doi.org/10.4155/tde.12.68
State	Published - Jul 2012
Externally published	Yes

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.4155/tde.12.68

Cite this

@article{ff82cfe47df442c2bd678935be0beab0,

title = "High-dose monoclonal antibodies via the subcutaneous route: Challenges and technical solutions, an industry perspective",

abstract = "This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.",

author = "Chakravarthy Narasimhan and Henryk MacH and Mohammed Shameem",

year = "2012",

month = jul,

doi = "10.4155/tde.12.68",

language = "English",

volume = "3",

pages = "889--900",

journal = "Therapeutic Delivery",

issn = "2041-5990",

publisher = "Taylor and Francis Ltd.",

number = "7",

}

TY - JOUR

T1 - High-dose monoclonal antibodies via the subcutaneous route

T2 - Challenges and technical solutions, an industry perspective

AU - Narasimhan, Chakravarthy

AU - MacH, Henryk

AU - Shameem, Mohammed

PY - 2012/7

Y1 - 2012/7

N2 - This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.

AB - This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.

UR - https://www.scopus.com/pages/publications/84864579215

U2 - 10.4155/tde.12.68

DO - 10.4155/tde.12.68

M3 - Review article

C2 - 22900469

AN - SCOPUS:84864579215

SN - 2041-5990

VL - 3

SP - 889

EP - 900

JO - Therapeutic Delivery

JF - Therapeutic Delivery

IS - 7

ER -

High-dose monoclonal antibodies via the subcutaneous route: Challenges and technical solutions, an industry perspective

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this